This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
UK Housing Sector (BDEV, BKG, PSN, TW.) - A disappointing RICS House Price Index print overnight (1.0% vs 4.0% expected) could have an impact on UK Housebuilders at the open. London saw more respondents report falling prices than at any other time since 2009.
AstraZeneca (AZN) - The Pharmaceutical giant announces that it expects its FY loss to be less than previously expected, effectively upping guidance, as a sales decline in older drugs slowed. Q3 revenues improved 9% to top analysts' estimates ($6.2bn vs $6.0bn exp.) alongside earnings-per-share ($1.12 vs £1.09 exp.).
Hikma Pharmaceuticals (HIK) - The company continues to expect revenue and core operating profit broadly in line with 2016 performance due to favourable FX impact, although outstanding issues remain with generic drug advair.
National Grid (NG.) - The energy provider has maintained its FY outlook, raised its dividend 2.1% in line with policy while expecting a stronger H2.
Sainsburys (SBRY) - The big four supermarket has reduced its interim dividend by 0.5p (-14%) as H1 underlying pre-tax profit falls 9% YoY. However, the company reported like-for-like sales increase 1.6% during the period despite concerns of changing consumer spending patterns and reiterated guidance.
(Sources: Company Newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| MARKS & SPENCER GROUP | MKS | 1.6% | 5.0% | -3.6% |
| PERSIMMON | PSN | -3.5% | -0.9% | -4.2% |
| SKY | SKY | 0.4% | 0.5% | -0.2% |
| TULLOW OIL | TLW | 0.9% | 3.7% | -0.4% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research